Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Treatment resistance is observed in all advanced cancers. Colorectal cancer (CRC) presenting as colorectal adenocarcinoma (COAD) is the second leading cause of cancer deaths worldwide. Multimodality treatment includes surgery, chemotherapy, and targeted therapies with selective utilization of immuno...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa, Sunil Krishnan
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-05-01
סדרה:Frontiers in Oncology
נושאים:
KRAS
DDR1
BCR-ABL1
COAD
GBM
chemoradioresistance
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fonc.2022.840241/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים